OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
Douglas L. Huseby, Sha Cao, Edouard Zamaratski, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 9
Douglas L. Huseby, Sha Cao, Edouard Zamaratski, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 9
Showing 9 citing articles:
A Review of Antibacterial Candidates with New Modes of Action
Mark S. Butler, Waldemar Vollmer, Emily C. A. Goodall, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 10, pp. 3440-3474
Open Access | Times Cited: 16
Mark S. Butler, Waldemar Vollmer, Emily C. A. Goodall, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 10, pp. 3440-3474
Open Access | Times Cited: 16
Airborne Escherichia coli bacteria biosynthesize lipids in response to aerosolization stress
Brooke L. Smith, Meiyi Zhang, Maria D. King
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Brooke L. Smith, Meiyi Zhang, Maria D. King
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Understanding Compound Efflux from Gram-Negative Bacteria, a Final Frontier for Antibiotic Discovery
Rebecca J. Ulrich, Paul J. Hergenrother
Microbial Drug Resistance (2025)
Closed Access
Rebecca J. Ulrich, Paul J. Hergenrother
Microbial Drug Resistance (2025)
Closed Access
Global health perspectives on antibacterial drug discovery and the preclinical pipeline
Ursula Theuretzbacher, Ravindra P. Jumde, Alan J. Hennessy, et al.
Nature Reviews Microbiology (2025)
Closed Access
Ursula Theuretzbacher, Ravindra P. Jumde, Alan J. Hennessy, et al.
Nature Reviews Microbiology (2025)
Closed Access
Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors
Andrea Benediktsdottir, Sanjeewani Sooriyaarachchi, Sha Cao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116790-116790
Open Access
Andrea Benediktsdottir, Sanjeewani Sooriyaarachchi, Sha Cao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116790-116790
Open Access
Adjunctive phage therapy improves antibiotic treatment of Ventilator-Associated-Pneumonia with Pseudomonas aeruginosa
Chantal Weissfuss, Jingjing Li, Ulrike Behrendt, et al.
Research Square (Research Square) (2024)
Closed Access
Chantal Weissfuss, Jingjing Li, Ulrike Behrendt, et al.
Research Square (Research Square) (2024)
Closed Access
Lipoprotein transport system Lol may be a selective target for Gram-negative bacteria
Qiang Yang, Ying Cai, Zhibo Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Qiang Yang, Ying Cai, Zhibo Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Design and Evaluation of Pyridinyl Sulfonyl Piperazine LpxH Inhibitors with Potent Antibiotic Activity Against Enterobacterales
Amanda F. Ennis, C. Skyler Cochrane, Patrick A. Dome, et al.
JACS Au (2024) Vol. 4, Iss. 11, pp. 4383-4393
Open Access
Amanda F. Ennis, C. Skyler Cochrane, Patrick A. Dome, et al.
JACS Au (2024) Vol. 4, Iss. 11, pp. 4383-4393
Open Access
